The clinical process in psychiatry: A clinimetric approach

Journal of Clinical Psychiatry

Volumn 73, Issue 2, 2012, Pages 177-184

  Fava, Giovanni A ^a,b   Rafanelli, Chiara ^a   Tomba, Elena ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ASYMPTOMATIC DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINIMETRICS; COMORBIDITY; DATA ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC REASONING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; ILLNESS BEHAVIOR; MEDICAL LITERATURE; MEDLINE; PHENOMENOLOGY; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL WELL BEING; PSYCHOTHERAPY; REVIEW; TREND STUDY;

EID: 84857755977     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10r06444     Document Type: Review

References (75)

1. Maj M, Gaebel W, Lopez-Ibor JJ, et al, eds. Psychiatric Diagnosis and Classification. Chichester, UK: Wiley; 2002. doi:10.102/047084647X
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
3. Mezzich JE, Salloum IM. Towards innovative international classification and diagnostic systems: ICD-11 and person-centered integrative diagnosis. Acta Psychiatr Scand. 2007;116(1):1-5. doi:10.1/j.160-047.207.01028.x PubMed (Pubitemid 46889767)
4. Frances A. Whither DSM-V? Br J Psychiatry. 2009;195(5):391-392. doi:10.192/bjp.bp.109.073932 PubMed
5. American Psychiatric Association. Psychiatric Evaluation of Adults. Second Edition. Am J Psychiatry. 2006; 163 (June suppl): 1-36
6. Feinstein AR. Clinical Judgment. Baltimore, MD: Williams & Wilkins; 1967.
7. Feinstein AR. T. Duckett Jones Memorial Lecture: The Jones criteria and the challenges of clinimetrics. Circulation. 1982;66(1):1-5. PubMed
8. Feinstein AR. Clinimetrics. New Haven, CT: Yale University Press; 1987.
9. Fava GA, Kellner R. Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand. 1993;87(4):225-230. doi:10.1/j.160-047. 193.tb0362.x PubMed (Pubitemid 23107270)
10. Fava GA, Ruini C, Rafanelli C. Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom. 2004;73(3):145-148. doi:10.159/076451 PubMed (Pubitemid 38437717)
11. Hunsley J, Meyer GJ. The incremental validity of psychological testing and assessment: conceptual, methodological, and statistical issues. Psychol Assess. 2003;15(4):446-455. doi:10.1037/1040-3590.15.4.46 PubMed (Pubitemid 37548965)
12. Garb HN. Incremental validity and the assessment of psychopathology in adults. Psychol Assess. 2003;15(4):508-520. doi:10.1037/1040-3590.15.4.508 PubMed (Pubitemid 37548970)
13. Feinstein AR. An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J Biol Med. 1973;46(3):212-232. PubMed
14. Zimmerman M, Chelminski I, McDermut W. Major depressive disorder and Axis I diagnostic comorbidity. J Clin Psychiatry. 2002;63(3):187-193. PubMed (Pubitemid 34407076)
15. Cloninger CR. Implications of comorbidity for the classification of mental disorders: the need for a psychobiology of coherence. In: Maj M, Gaebel W, Lopez-Ibor JJ, et al, eds. Psychiatric Diagnosis and Classification. Chichester, UK: Wiley; 2002:79-106. doi:10.102/047084647X.ch4
16. Sherbourne CD, Wells KB. Course of depression in patients with comorbid anxiety disorders. J Affect Disord. 1997;43(3):245-250. doi:10.1016/S0165- 0327(97)0142-0 PubMed (Pubitemid 27242471)
17. Rust J, Golombok S. Modern Psychometrics: The Science of Psychological Assessment. London, UK: Routledge; 1989.
18. Detre TP, Jarecki H. Modern Psychiatric Treatment. Philadelphia, PA: Lippincott; 1971.
19. Fava GA. Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med. 1999;29(1):47-61. doi:10.1017/ S0329179807429 PubMed (Pubitemid 29034522)
20. Fava GA, Mangelli L. Subclinical symptoms of panic disorder: new insights into pathophysiology and treatment. Psychother Psychosom. 1999;68(6):281-289. doi:10.159/012345 PubMed (Pubitemid 29516391)
21. Fava GA, Ruini C, Rafanelli C. Sequential treatment of mood and anxiety disorders. J Clin Psychiatry. 2005;66(11):1392-1400. doi:10.408/JCP.v6n108 PubMed (Pubitemid 41779537)
22. Robins E, Guze SB. Classification of affective disorders: the primarysecondary, the endogenous-reactive, and the neurotic-psychotic concepts. In: Williams TA, Katz MM, Shield JA, eds. Recent Advances in the Psychobiology of the Depressive Illness. Washington, DC: Government Printing Office; 1972:283-293.
23. Lichtenberg P, Belmaker RH. Subtyping major depressive disorder. Psychother Psychosom. 2010;79(3):131-135. doi:10.159/0286957 PubMed
24. Bech P. Struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psychosom. 2010; 79(6):331-338. doi:10.159/032018 PubMed
25. Tyrer P, Seivewright N, Ferguson B, et al. The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder. Acta Psychiatr Scand. 1992;85(3):201-206. doi:10.1/j.160-047.192.tb08595.x PubMed
26. Slater E, Slater P. A heuristic theory of neurosis. J Neurol Neurosurg Psychiatry. 1944;7(1-2):49-55. doi:10.136/jnp.7.1-2.49
27. Taylor GJ. Affects, trauma, and mechanisms of symptom formation: a tribute to John C. Nemiah, MD (1918-2009). Psychother Psychosom. 2010;79(6):339-349. doi:10.159/032019 PubMed
28. Fava GA, Rafanelli C, Tossani E, et al. Agoraphobia is a disease: a tribute to Sir Martin Roth. Psychother Psychosom. 2008;77(3):133-138. doi:10.159/01606 PubMed (Pubitemid 351442715)
29. van Praag HM. Diagnosing depression - looking backward into the future. Psychiatr Dev. 1989;7(4):375-394. PubMed
30. Rafanelli C, Park SK, Ruini C, et al. Rating well-being and distress. Stress Med. 2000;16(1):55-61. (Pubitemid 30103514)
31. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87(3):873-904. doi:10.152/physrev.041.206 PubMed (Pubitemid 47086281)
32. Fava GA, Guidi J, Semprini F, et al. Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom. 2010;79(5):280-284. doi:10.159/0318294 PubMed
33. Fava M, Evins AE, Dorer DJ, et al. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom. 2003;72(3): 115-127. doi:10.159/069738 PubMed (Pubitemid 36469860)
34. McGorry P, Hickie IB, Yung AR, et al. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):612-622.
35. Fava GA, Tomba E, Grandi S. The road to recovery from depression - don't drive today with yesterday's map. Psychother Psychosom. 2007; 76(5):260-265. doi:10.159/0104701 PubMed (Pubitemid 47262743)
36. Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord. 2007;100(1-3):279-281. doi:10.1016/j.jad.207.03.07 PubMed (Pubitemid 46818451)
37. Kapczinski F, Dias VV, Kauer-Sant'Anna M, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1366-1371. doi:10.1016/j.pnpbp. 209.07.027 PubMed
38. Reinares M, Colom F, Rosa AR, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010;123(1-3):81-86. doi:10.1016/j.jad.209.09.09 PubMed
39. Maguire S, Le Grange D, Surgenor L, et al. Staging anorexia nervosa: conceptualizing illness severity. Early Interv Psychiatry. 2008;2(1):3-10. doi:10.1/j.1751-7893.207.049.x
40. Bilsbury CD, Richman A. A staging approach to measuring patient-centred subjective outcomes. Acta Psychiatr Scand. 2002; 106(suppl s414):5-40. doi:10.1046/j.01-690x.202.052.x
41. Andresen R, Caputi P, Oades L. Stages of recovery instrument: development of a measure of recovery from serious mental illness. Aust N Z J Psychiatry. 2006;40(11-12):972-980. PubMed (Pubitemid 44575015)
42. Fava GA, Grandi S, Zielezny M, et al. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry. 1994;151(9):1295-1299. PubMed (Pubitemid 24281752)
43. Fava GA, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry. 1998;55(9):816-820. doi:10.101/archpsyc.5.9.816 PubMed (Pubitemid 28413044)
44. Fava GA, Grandi S, Zielezny M, et al. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1996;153(7):945-947. PubMed (Pubitemid 26225469)
45. Fava GA, Ruini C, Rafanelli C, et al. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161(10):1872-1876. doi:10.176/api.ajp.161.10.1872 PubMed (Pubitemid 39314682)
46. Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom FE, Kupfer DT, eds. Psychopharmacology: the Fourth Generation of Progress. New York, NY: Raven Press; 1995:1081-1097.
47. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649-659. doi:10.1016/S06-323(03)0231-2 PubMed (Pubitemid 39658481)
48. Fekadu A, Wooderson SC, Markopoulou K, et al. The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms. J Clin Psychiatry. 2009;70(7): 952-957. doi:10.408/JCP.08m04728 PubMed
49. Petersen T, Papakostas GI, Posternak MA, et al. Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharmacol. 2005;25(4):336-341. doi:10.1097/01.jcp.0169036.4075.16 PubMed (Pubitemid 41060253)
50. Nierenberg AA, Amsterdam JD. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry. 1990;51(suppl):39-47, discussion 48-50. PubMed
51. Fava GA. Can long-term treatment with antidepressant drugs worsen the course of depression? J Clin Psychiatry. 2003;64(2):123-133. doi:10.408/JCP.v64n0204 PubMed (Pubitemid 36268314)
52. Di Clemente CC, Prochaska JO. Toward a comprehensive, transtheoretical model of change: stages of change and addictive behaviours. In: Miller WR, Heather N, eds. Treating Addictive Behaviors. 2nd ed. New York, NY: Plenum; 1998:3-24.
53. Porcelli P, Sonino N, eds. Psychological Factors Affecting Medical Conditions. A New Classification for DSM-V. Basel, Switzerland: Karger; 2007.
54. Fava GA, Sonino N. Psychosomatic assessment. Psychother Psychosom. 2009;78(6):333-341. doi:10.159/0235736 PubMed
55. Wise TN. Diagnostic criteria for psychosomatic research are necessary for DSM V. Psychother Psychosom. 2009;78(6):330-332. doi:10.159/0235735 PubMed
56. Lewis A. The psychopathology of insight. Br J Med Psychol. 1934;14: 332-348.
57. Fava GA, Porcelli P, Rafanelli C, et al. The spectrum of anxiety disorders in the medically ill. J Clin Psychiatry. 2010;71(7):910-914. doi:10.408/JCP.10m060blu PubMed
58. Cockram CA, Doros G, de Figueiredo JM. Diagnosis and measurement of subjective incompetence: the clinical hallmark of demoralization. Psychother Psychosom. 2009;78(6):342-345. doi:10.159/0235737 PubMed
59. Ogrodniczuk JS, Piper WE, Joyce AS, et al. Alexithymia and treatment preferences among psychiatric outpatients. Psychother Psychosom. 2009; 78(6):383-384. doi:10.159/0235981 PubMed
60. Fava GA, Tomba E. Increasing psychological well-being and resilience by psychotherapeutic methods. J Pers. 2009;77(6):1903-1934. doi:10.1/j.1467-6494. 209.0604.x PubMed
61. Ralph RO, Corrigan PW, eds. Recovery in Mental Illness. Broadening our Understanding of Wellness. Washington, DC: American Psychological Association; 2005. doi:10.1037/10848-0
62. Feinstein AR. The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23(7):455-468. doi:10.1016/021-9681(70) 9054-8
63. de Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003; 56(3):221-229. doi:10.1016/S0895-4356(02)0585-1 PubMed (Pubitemid 36513483)
64. Emmelkamp PMG, Bouman TK, Scholing A. Anxiety Disorders. Chichester, UK: Wiley; 1993:55-67.
65. Emmelkamp PMG. The additional value of clinimetrics needs to be established rather than assumed. Psychother Psychosom. 2004;73(3): 142-144. doi:10.159/076450 PubMed (Pubitemid 38437716)
66. Joosten EAG, DeFuentes-Merillas L, de Weert GH, et al. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77(4): 219-226. doi:10.159/0126073 PubMed (Pubitemid 351685446)
67. Joosten EAG, de Jong CAJ, de Weert-van Oene GH, et al. Shared decision-making reduces drug use and psychiatric severity in substancedependent patients. Psychother Psychosom. 2009;78(4):245-253. doi:10.159/0219524 PubMed
68. Reus VI, Weingartner H, Post RM. Clinical implications of state-dependent learning. Am J Psychiatry. 1979;136(7):927-931. PubMed (Pubitemid 9211599)
69. Targum SD, Pollack MH, Fava M. Redefining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008;14(1):2-9. doi:10.1/j.175-5949. 208.038.x PubMed
70. Engel GL. Physician-scientists and scientific physicians: resolving the humanism-science dichotomy. Am J Med. 1987;82(1):107-111. doi:10.1016/02- 9343(87)90384-6 PubMed
71. Fava GA. The intellectual crisis of psychiatric research. Psychother Psychosom. 2006;75(4):202-208. doi:10.159/092890 PubMed (Pubitemid 43938871)
72. Maj M. Are psychiatrists an endangered species? World Psychiatry. 2010;9(1):1-2. PubMed
73. Katschnig H. Are psychiatrists an endangered species? observations on internal and external challenges to the profession. World Psychiatry. 2010;9(1):21-28. PubMed
74. Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004;116(3): 179-185. doi:10.1016/j.amjmed.203.09.031 PubMed (Pubitemid 38121675)
75. Wise TN. Curiosity and crisis. Psychother Psychosom. 2006;75(4): 199-201. (Pubitemid 43938870)